(Reuters) - Ventana Medical Systems Inc. , a tissue-based
diagnostics specialist, received a takeover offer from Swiss
drug maker Roche late on Monday, sending Ventana
shares up 52 percent to $78.75 in electronic composite
trading.
"There have been so many rumors that there will be no more
deals being done. VMSI getting taken out by Roche helps the
market out," said Todd Leone, head of listed trading at Cowen &
Co. in New York.
Read more at Reuters.com Bonds News
diagnostics specialist, received a takeover offer from Swiss
drug maker Roche late on Monday, sending Ventana
shares up 52 percent to $78.75 in electronic composite
trading.
"There have been so many rumors that there will be no more
deals being done. VMSI getting taken out by Roche helps the
market out," said Todd Leone, head of listed trading at Cowen &
Co. in New York.
Read more at Reuters.com Bonds News
No comments:
Post a Comment